Trophos to lead new MitoCare consortium

MARSEILLE, France—Trophos SA has announced a €6 million ($8.05 million) European Union award to support MitoCare, a two-and-a-half year international, translational medicine project involving a 16-partner consortium to be led by Trophos, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology